(Q44512674)

English

Effect of pravastatin on intermediate-density and low-density lipoproteins containing apolipoprotein CIII in patients with diabetes mellitus

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 December 2017

Effect of pravastatin on intermediate-density and low-density lipoproteins containing apolipoprotein CIII in patients with diabetes mellitus (English)

1 reference

Europe PubMed Central

3 December 2017

1 reference

based on heuristic

inferred from title

author name string

Sung-Joon Lee

1

1 reference

Europe PubMed Central

3 December 2017

Frank M Sacks

2

1 reference

Europe PubMed Central

3 December 2017

language of work or name

0 references

publication date

1 July 2003

1 reference

Europe PubMed Central

3 December 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

3 December 2017

92

1 reference

Europe PubMed Central

3 December 2017

2

1 reference

Europe PubMed Central

3 December 2017

121-124

1 reference

Europe PubMed Central

3 December 2017

Insulin resistance syndrome and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900524-1

7 January 2021

Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900524-1

7 January 2021

Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900524-1

7 January 2021

Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900524-1

7 January 2021

Logistic discriminant analysis of lipids and apolipoproteins in a population of coronary bypass patients and the significance of apolipoproteins C-III and E.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900524-1

7 January 2021

The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900524-1

7 January 2021

VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900524-1

7 January 2021

Triglycerides, apo C3 and Lp B:C3 and cardiovascular risk in type II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900524-1

7 January 2021

LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900524-1

7 January 2021

Effect of pravastatin on apolipoproteins B and C-III in very-low-density lipoproteins and low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900524-1

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900524-1

7 January 2021

Hypertriglyceridemia but not diabetes status is associated with VLDL containing apolipoprotein CIII in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900524-1

7 January 2021

Very-fast ultracentrifugation of human plasma lipoproteins: influence of the centrifugal field on lipoprotein composition.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900524-1

7 January 2021

Very fast ultracentrifugation of serum lipoproteins: influence on lipoprotein separation and composition

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900524-1

7 January 2021

Identifiers

10.1016/S0002-9149(03)00524-1

1 reference

Europe PubMed Central

3 December 2017

1 reference

Europe PubMed Central

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44512674&oldid=2026563493"